These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19648788)

  • 21. Infectious profile in children with ALL during chemotherapy: A report of study group for infections.
    Zawitkowska J; Drabko K; Szmydki-Baran A; Zaucha-Prażmo A; Lejman M; Czyżewski K; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Kulicka E; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Klepacka J; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Woszczyk M; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Musiał J; Styczyński J
    J Infect Chemother; 2019 Oct; 25(10):774-779. PubMed ID: 31101529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Seibel NL; Steinherz PG; Sather HN; Nachman JB; Delaat C; Ettinger LJ; Freyer DR; Mattano LA; Hastings CA; Rubin CM; Bertolone K; Franklin JL; Heerema NA; Mitchell TL; Pyesmany AF; La MK; Edens C; Gaynon PS
    Blood; 2008 Mar; 111(5):2548-55. PubMed ID: 18039957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
    Gaynon PS; Bleyer WA; Steinherz PG; Finklestein JZ; Littman PS; Miller DR; Reaman GH; Sather HN; Hammond GD
    Am J Pediatr Hematol Oncol; 1988; 10(1):42-50. PubMed ID: 3056061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Etiology and structure of infectious complications of cytostatic therapy in children with acute lymphoblastic leukemia and non-B-cell non-Hodgkin lymphomas].
    Peshikova MV; Dolgushin II; Rusanova NN
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (1):70-1. PubMed ID: 11949261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
    Tolar J; Bostrom BC; La MK; Sather HN
    Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group.
    Termuhlen AM; Smith LM; Perkins SL; Lones M; Finlay JL; Weinstein H; Gross TG; Abromowitch M
    Br J Haematol; 2013 Sep; 162(6):792-801. PubMed ID: 23889312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
    Hutchinson RJ; Gaynon PS; Sather H; Bertolone SJ; Cooper HA; Tannous R; Wells LM; Heerema NA; Sailer S; Trigg ME;
    J Clin Oncol; 2003 May; 21(9):1790-7. PubMed ID: 12721256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children's Oncology Group.
    Steinherz PG; Seibel NL; Sather H; Ji L; Xu X; Devidas M; Gaynon PS
    Leukemia; 2019 Sep; 33(9):2144-2154. PubMed ID: 30816331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
    Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
    Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 32. Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
    Raetz EA; Borowitz MJ; Devidas M; Linda SB; Hunger SP; Winick NJ; Camitta BM; Gaynon PS; Carroll WL
    J Clin Oncol; 2008 Aug; 26(24):3971-8. PubMed ID: 18711187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
    Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
    Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
    Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.
    Maloney KW; Devidas M; Wang C; Mattano LA; Friedmann AM; Buckley P; Borowitz MJ; Carroll AJ; Gastier-Foster JM; Heerema NA; Kadan-Lottick N; Loh ML; Matloub YH; Marshall DT; Stork LC; Raetz EA; Wood B; Hunger SP; Carroll WL; Winick NJ
    J Clin Oncol; 2020 Feb; 38(6):602-612. PubMed ID: 31825704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962).
    Kurre HA; Ettinger AG; Veenstra DL; Gaynon PS; Franklin J; Sencer SF; Reaman GH; Lange BJ; Holcenberg JS
    J Pediatr Hematol Oncol; 2002; 24(3):175-81. PubMed ID: 11990302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.
    Gaynon PS; Trigg ME; Heerema NA; Sensel MG; Sather HN; Hammond GD; Bleyer WA
    Leukemia; 2000 Dec; 14(12):2223-33. PubMed ID: 11187913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
    Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC;
    Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
    Hakim H; Dallas R; Zhou Y; Pei D; Cheng C; Flynn PM; Pui CH; Jeha S
    Cancer; 2016 Mar; 122(5):798-805. PubMed ID: 26700662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy.
    Okcu MF; Roberts WM; Johnston DA; Ouspenskaia MV; Papusha VZ; Brandt MA; Zipf TF
    Leuk Res; 2003 Aug; 27(8):743-50. PubMed ID: 12801533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.